LONDON, July 15 (Reuters) - Positive news on initial trials
of the University of Oxford's potential COVID-19 vaccine that
has been licensed to AstraZeneca could be announced as
soon as Thursday, ITV's political editor Robert Peston said,
citing a source.
The project has started Phase III of the human trials to
assess how the vaccine works in a large number of people over
the age of 18, but has yet to report Phase I trial results.
The developers of the vaccine earlier this month said they
are encouraged by the immune response they have seen in trials
so far.
"I am hearing there will be positive news soon (perhaps
tomorrow) on initial trials of the Oxford Covid-19 vaccine that
is backed by AstraZeneca," Peston said in a blog post on
Wednesday.
(Reporting by William Schomberg, writing by Alistair Smout;
editing by Michael Holden)
Astrazeneca (AZN)
